Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experience. - Hersh EM; Metch BS; Muggia FM; Brown TD; Whitehead RP; Budd GT; Rinehart JJ; Crawford ED; Bonnet JD; Behrens BC (Journal of immunotherapy : official journal of the Society for Biological Therapy, 1991)